Nevertheless, this study provides preliminary evidence that potentially unfavorable combinations of polymorphisms from the HMGB1/RAGE axis could synergistically affect the onset and progression of hepatocellular carcinoma. The gene discussed is HMGB1; the disease is hepatocellular carcinoma.